NCT04550962 - Description of Characteristics, Such as Age, Previous and Concurrent Treatments, Associated Diseases, of Patients With Asthma Treated With Dupilumab (DUPIXENT) | Biotech Hunter

Enrollment

376

Participants

Timeline

Start Date

November 2, 2020

Primary Completion Date

July 1, 2026

Study Completion Date

July 1, 2026

Conditions

Asthma

Interventions

DRUG

Dupilumab SAR231893

"Pharmaceutical form:solution Route of administration: subcutaneous~Dose regimen:"

Trial Locations (41)

2

Investigational Site Number : 7840007, Dubai

1631

Investigational Site Number : 0320006, Villa Rosa

3000

Investigational Site Number : 0320004, Santa Fe

3499

Investigational Site Number : 7840002, Sharjah city

4545

Investigational Site Number : 7840001, Dubai

11525

Investigational Site Number : 6820002, Riyadh

12713

Investigational Site Number : 6820001, Riyadh

23433

Investigational Site Number : 6820005, Jeddah

24246

Investigational Site Number : 6820004, Mecca

34000

Investigational Site Number : 4840003, Durango

64239

Investigational Site Number : 3760007, Tel Aviv

78278

Investigational Site Number : 3760004, Ashkelon

91031

Investigational Site Number : 3760005, Jerusalem

91120

Investigational Site Number : 3760003, Jerusalem

105077

Investigational Site Number : 6430007, Moscow

115522

Investigational Site Number : 6430004, Moscow

119074

Investigational Site Number : 7020002, Singapore

169308

Investigational Site Number : 7020001, Singapore

344012

Investigational Site Number : 6430006, Rostov-on-Don

355020

Investigational Site Number : 6430002, Stavropol

410012

Investigational Site Number : 6430008, Saratov

454091

Investigational Site Number : 6430005, Chelyabinsk

2260877

Investigational Site Number : 1520002, Quillota

4428164

Investigational Site Number : 3760001, Kfar Saba

7500692

Investigational Site Number : 1520001, Santiago

7642001

Investigational Site Number : 3760006, Rehovot

7747629

Investigational Site Number : 3760008, Ashdod

B1900BNN

Investigational Site Number : 0320005, La Plata

C1121ABE

Investigational Site Number : 0320001, Ciudad Autonoma Bs As

C1425BEN

Investigational Site Number : 0320008, Ciudad Autonoma Buenos Aires

T4000IAI

Investigational Site Number : 0320009, San Miguel de Tucumán

080001

Investigational Site Number : 1700009, Barranquilla

Unknown

Investigational Site Number : 1700004, Bogotá

Investigational Site Number : 1700003, Bucaramanga

Investigational Site Number : 4220001, Beirut

Investigational Site Number : 4220003, El Achrafiyé

Investigational Site Number : 6340001, Doha

00000

Investigational Site Number : 4140001, Kuwait City

Investigational Site Number : 7840004, Sharjah city

11 0236

Investigational Site Number : 4220002, Beirut

0000

Investigational Site Number : 7840006, Abu Dhabi